Jeffrey Newcorn, MD
Icahn School of Medicine at Mount Sinai
8
8
5
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Iliyan Ivanov, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Anthony Spirito, PhD
Brown University
Shared therapeutic areas:
Worked with same sponsors:
Tanya Froehlich, MD
Children's Hospital Medical Center, Cincinnati
Shared therapeutic areas:
Worked with same sponsors:
Kurt Schulz, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Mark Stein, PhD
University of Washington
Shared therapeutic areas:
Worked with same sponsors:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Worked with same sponsors:
Daniel S Pine, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Worked with same sponsors:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Worked with same sponsors:
Ru-Lan Hsieh, MD
Shin Kong Wu Ho-Su Memorial Hospital
Shared therapeutic areas:
Sabine Wilhelm, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation
Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
All 8 trials loaded